- New Products include the Arria® 10, Stratix® V, Stratix IV, Arria V, Arria II, Cyclone® V, Cyclone IV, MAX® 10, MAX V, HardCopy® IV devices and Enpirion PowerSoCs.
- Mainstream Products include the Stratix III, Cyclone III, MAX II and HardCopy III devices.
- Mature and Other Products include the Stratix II, Stratix, Arria GX, Cyclone II, Cyclone, MAX 3000A, MAX 7000, MAX 7000A, MAX 7000B, MAX 7000S, MAX 9000, HardCopy II, HardCopy, FLEX® series, APEX™ series, Mercury™, Excalibur™ devices, configuration and other devices, intellectual property cores, and software and other tools.
Forward-Looking Statements
Statements in this press release that are not historical are "forward-looking statements" as the term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally written in the future tense and/or preceded by words such as "will," "expects," "anticipates," or other words that imply or predict a future state. Forward-looking statements include, but are not limited to, statements regarding data center application growth potential. Investors are cautioned that all forward-looking statements in this release involve risks and uncertainty that can cause actual results to differ materially from those currently anticipated due to a number of factors, including without limitation, changing global economic conditions and other risk factors discussed in documents filed by the company with the Securities and Exchange Commission (SEC) from time to time. Copies of Altera's SEC filings are posted on the company's website and are available from the company without charge. Forward-looking statements are made as of the date of this release, and, except as required by law, the company does not undertake an obligation to update its forward-looking statements to reflect future events or circumstances.
About Altera
Altera® programmable solutions enable designers of electronic systems to rapidly and cost effectively innovate, differentiate and win in their markets. Altera offers FPGA, SoC, CPLD products, and complementary technologies, such as power solutions, to provide high-value solutions to customers worldwide. Visit www.altera.com.
ALTERA, ARRIA, CYCLONE, ENPIRION, MAX, MEGACORE, NIOS, QUARTUS and STRATIX words and logos are trademarks of Altera Corporation and registered in the U.S. Patent and Trademark Office and in other countries. All other words and logos identified as trademarks or service marks are the property of their respective holders as described at www.altera.com/legal.
ALTERA CORPORATION | ||||||||||||||||||||
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | ||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||
| ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
| ||||||||||
|
|
Three Months Ended |
|
Nine Months Ended | ||||||||||||||||
(In thousands, except per share amounts) |
|
September 25,
|
|
June 26,
|
|
September 26,
|
|
September 25,
|
|
September 26,
| ||||||||||
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Net sales |
|
$ |
399,567 |
|
|
$ |
414,162 |
|
|
$ |
499,606 |
|
|
$ |
1,249,214 |
|
|
$ |
1,452,216 |
|
Cost of sales |
|
133,667 |
|
|
126,590 |
|
|
166,019 |
|
|
416,520 |
|
|
480,279 |
| |||||
Gross margin |
|
265,900 |
|
|
287,572 |
|
|
333,587 |
|
|
832,694 |
|
|
971,937 |
| |||||
Operating expense |
|
|
|
|
|
|
|
|
|
| ||||||||||
Research and development expense |
|
100,481 |
|
|
105,345 |
|
|
112,078 |
|
|
309,057 |
|
|
310,856 |
| |||||
Selling, general, and administrative expense |
|
74,745 |
|
|
75,011 |
|
|
77,724 |
|
|
220,262 |
|
|
231,205 |
| |||||
Amortization of acquisition-related intangible assets |
|
2,491 |
|
|
2,427 |
|
|
2,465 |
|
|
7,382 |
|
|
7,394 |
| |||||
Merger expenses |
|
10,421 |
|
|
18,458 |
|
|
— |
|
|
28,879 |
|
|
— |
| |||||
Total operating expense |
|
188,138 |
|
|
201,241 |
|
|
192,267 |
|
|
565,580 |
|
|
549,455 |
| |||||
Operating margin (2) |
|
77,762 |
|
|
86,331 |
|
|
141,320 |
|
|
267,114 |
|
|
422,482 |
| |||||
Compensation (benefit)/expense — deferred compensation plan |
|
(4,468) |
|
|
2,732 |
|
|
(487) |
|
|
(1,709) |
|
|
4,093 |
| |||||
Loss/(gain) on deferred compensation plan securities |
|
4,468 |
|
|
(2,732) |
|
|
487 |
|
|
1,709 |
|
|
(4,093) |
| |||||
Interest income and other |
|
(9,590) |
|
|
(8,495) |
|
|
(4,558) |
|
|
(24,681) |
|
|
(18,362) |
| |||||
Gain reclassified from other comprehensive income |
|
(1,644) |
|
|
(1,463) |
|
|
(59) |
|
|
(5,613) |
|
|
(150) |
| |||||
Interest expense |
|
10,772 |
|
|
10,859 |
|
|
10,774 |
|
|
32,039 |
|
|
32,139 |
| |||||
Income before income taxes |
|
78,224 |
|
|
85,430 |
|
|
135,163 |
|
|
265,369 |
|
|
408,855 |
| |||||
Income tax expense |
|
16,706 |
|
|
15,091 |
|
|
17,154 |
|
|
38,660 |
|
|
47,328 |
| |||||
Net income |
|
61,518 |
|
|
70,339 |
|
|
118,009 |
|
|
226,709 |
|
|
361,527 |
| |||||
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Other comprehensive income/(loss): |
|
|
|
|
|
|
|
|
|
| ||||||||||
Unrealized gain/(loss) on investments: |
|
|
|
|
|
|
|
|
|
| ||||||||||
Unrealized holding gain/(loss) on investments arising during period, net of tax of $190, ($460), ($6), ($228) and $41 |
|
13,058 |
|
|
(24,805) |
|
|
(4,929) |
|
|
5,038 |
|
|
22,102 |
| |||||
Less: Reclassification adjustments for gain on investments included in net income, net of tax of ($1), $9, $11, $15 and $21 |
|
(1,644) |
|
|
(1,454) |
|
|
(48) |
|
|
(5,598) |
|
|
(129) |
| |||||
Other comprehensive income/(loss) |
|
11,414 |
|
|
(26,259) |
|
|
(4,977) |
|
|
(560) |
|
|
21,973 |
| |||||
Comprehensive income |
|
$ |
72,932 |
|
|
$ |
44,080 |
|
|
$ |
113,032 |
|
|
$ |
226,149 |
|
|
$ |
383,500 |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Net income per share: |
|
|
|
|
|
|
|
|
|
| ||||||||||
Basic |
|
$ |
0.20 |
|
|
$ |
0.23 |
|
|
$ |
0.38 |
|
|
$ |
0.75 |
|
|
$ |
1.16 |
|
Diluted |
|
$ |
0.20 |
|
|
$ |
0.23 |
|
|
$ |
0.38 |
|
|
$ |
0.74 |
|
|
$ |
1.15 |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Shares used in computing per share amounts: |
|
|
|
|
|
|
|
|
|
| ||||||||||
Basic |
|
302,707 |
|
|
301,799 |
|
|
308,215 |
|
|
301,950 |
|
|
311,853 |
| |||||
Diluted |
|
305,337 |
|
|
304,604 |
|
|
310,184 |
|
|
304,421 |
|
|
314,130 |
| |||||
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Dividends per common share |
|
$ |
0.18 |
|
|
$ |
0.18 |
|
|
$ |
0.18 |
|
|
$ |
0.54 |
|
|
$ |
0.48 |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Tax rate |
|
21.4 |
% |
|
17.7 |
% |
|
12.7 |
% |
|
14.6 |
% |
|
11.6 |
% | |||||
% of Net sales: |
|
|
|
|
|
|
|
|
|
| ||||||||||
Gross margin |
|
66.5 |
% |
|
69.4 |
% |
|
66.8 |
% |
|
66.7 |
% |
|
66.9 |
% | |||||
Research and development (1) |
|
25.8 |
% |
|
26.0 |
% |
|
22.9 |
% |
|
25.3 |
% |
|
21.9 |
% | |||||
Selling, general, and administrative |
|
18.7 |
% |
|
18.1 |
% |
|
15.6 |
% |
|
17.6 |
% |
|
15.9 |
% | |||||
Operating margin (2) |
|
19.5 |
% |
|
20.8 |
% |
|
28.3 |
% |
|
21.4 |
% |
|
29.1 |
% | |||||
Net income |
|
15.4 |
% |
|
17.0 |
% |
|
23.6 |
% |
|
18.1 |
% |
|
24.9 |
% |